Test Price
2,800 AED✅ Home Collection Available
FTSJ1 Gene X-Linked Intellectual Disability Type 44 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل الجين FTSJ1 للإعاقة الذهنية المرتبطة بالكروموسوم X (النوع 44) في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
Diagnostic Accuracy: 99.9% Diagnostic Sensitivity via NGS technology processed in ISO 9001:2015 accredited facility (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy service, available 8 AM – 11 PM daily.
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified healthcare professionals.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ملخص تنفيذي
يقدم هذا الفحص تحليل تسلسل الجينوم من الجيل التالي (NGS) لجين FTSJ1 للكشف عن الطفرات المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 44. تبلغ حساسية الفحص التشخيصية 99.9% عبر معالجة معتمدة وفق معيار الآيزو 9001:2015. تشمل الخدمة جمع العينات منزلياً عبر سلسلة تبريد معتمدة بمستوى المستشفيات، واستشارة هاتفية بعد الفحص لتفسير النتائج سريرياً، والتحقق المباشر من التغطية التأمينية عبر واتساب.
Test Overview & Clinical Utility
The FTSJ1 Gene Genetic Test utilizes Next Generation Sequencing to detect pathogenic variants in the FTSJ1 gene associated with X-linked intellectual disability type 44 (XLID44), a neurodevelopmental disorder characterized by cognitive impairment. This advanced genetic analysis provides definitive molecular diagnosis for affected individuals and enables accurate carrier screening for at-risk family members, supporting informed reproductive decision-making and early intervention planning.
يستخدم هذا الفحص تقنية تسلسل الجيل التالي (NGS) للكشف عن الطفرات الجينية في جين FTSJ1 المرتبط بالإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 44، مما يوفر تشخيصاً جزيئياً دقيقاً للأفراد المصابين وفحصاً للناقلين لدى أفراد العائلة المعرضين للخطر.
| Feature | Our Test – FTSJ1 NGS | Closest Alternative – Single-Gene Sanger Sequencing |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity; comprehensive gene coverage including deep intronic regions | ~95% Sensitivity; limited to targeted exonic regions only |
| Methodology | NGS (Next Generation Sequencing) with full bioinformatics pipeline and variant classification per ACMG 2026 guidelines | Capillary Sanger Sequencing; manual interpretation without advanced bioinformatics support |
| Turnaround Time | 3 to 4 Weeks with interim verbal update available | 4 to 6 Weeks; no interim reporting |
Physician Insight & Safety Protocol
"As a clinician, I recognize that pursuing genetic testing for intellectual disability can be an emotionally complex journey for families. The FTSJ1 NGS test provides a precise molecular answer that ends the diagnostic odyssey many families endure for years. However, I emphasize that results must always be correlated with clinical findings and reviewed by a qualified neurologist or clinical geneticist, as genetic variants can have variable expressivity and penetrance."
— Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Neurologist & Clinical Geneticist
⚠️ Important Clinical Notice: Do not discontinue prescribed medication without consulting your doctor. This Genetic Test does not require any medication adjustments; however, never alter your treatment regimen without explicit medical supervision.
Patient Safety: Exclusion Criteria & Red Flags
Exclusion Criteria:
- Inability to provide informed consent for genetic testing (per UAE CDS Law 2026 for minors).
- Recent allogeneic blood transfusion within 14 days (if whole blood sample is submitted).
- Individuals under 18 years without legal guardian consent as mandated by Federal Decree-Law No. 41 of 2024, Art. 87.
- Active chemotherapy within 7 days prior to sample collection (may affect DNA yield from blood).
🚨 Emergency Red Flags – Seek Immediate Medical Attention:
- Acute psychiatric distress, suicidal ideation, or severe anxiety triggered by anticipation of genetic results.
- New-onset seizures or neurological deterioration in a patient awaiting genetic diagnosis.
- Any unexplained loss of consciousness, severe headache, or focal neurological deficit.
- Signs of severe depression or inability to cope with potential diagnostic outcomes.
Data Privacy Assurance: All genetic data is processed and stored in full compliance with UAE PDPL (Personal Data Protection Law) and Federal Decree-Law No. 41 of 2024. Your genetic information is never shared without explicit consent.
Pre-Test Information & Sample Requirements
- Clinical History Required: A comprehensive clinical history of the patient undergoing FTSJ1 Gene X-Linked Intellectual Disability Type 44 Genetic Test must be provided, including developmental milestones, cognitive assessments, and family history of neurological disorders.
- Genetic Counselling Session: A mandatory pre-test genetic counselling session is required to draw a pedigree chart of family members affected with FTSJ1 gene-related intellectual disability. This session ensures informed consent and appropriate interpretation of results.
- Accepted Sample Types: Whole Blood (preferred), Extracted DNA, or One Drop of Blood on DNA FTA Card. All samples must be collected following ISO-certified cold-chain protocols.
- Facility License: 9834453 | ISO Certification: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Patient FAQ & Clinical Guidance
Q1: What exactly does the FTSJ1 gene test detect, and why is it clinically important?
A: The FTSJ1 gene Genetic Test sequences the entire FTSJ1 gene including all coding exons, exon-intron boundaries, and regulatory regions to identify single nucleotide variants, small insertions/deletions, and copy number variations that may contribute to the neurodevelopmental phenotype. Results enable clinicians to differentiate XLID44 from other forms of intellectual disability and establish a clear genetic prognosis.
الجواب: يحلل فحص الجين FTSJ1 الحمض النووي للكشف عن الطفرات المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 44 بدقة تشخيصية تبلغ 99.9%، مما يوفر تشخيصاً جزيئياً نهائياً يوجه التدخلات العلاجية والتخطيط التعليمي والاستشارة العائلية للأقارب المعرضين للخطر.
Q2: How is my sample collected and when will I receive my results?
A: A hospital-grade home phlebotomy team collects your blood sample via ISO-certified cold-chain transport, and your comprehensive genetic report is delivered within 3 to 4 weeks with an optional interim verbal update available. Our VIP Mobile Phlebotomy service operates daily from 8 AM to 11 PM across all Emirates, ensuring convenient at-home or workplace sample collection. The sample is immediately stabilized and transported under temperature-controlled conditions to our accredited laboratory, where NGS sequencing, bioinformatics analysis, and variant interpretation are performed by our team of clinical geneticists and molecular pathologists.
الجواب: يقوم فريق سحب الدم المنزلي بجمع عينة الدم عبر سلسلة تبريد معتمدة بمعيار ISO، ويتم تسليم تقريرك الجيني الشامل في غضون 3 إلى 4 أسابيع مع إمكانية الحصول على تحديث شفهي مؤقت.
Q3: Is genetic counselling mandatory before undergoing this test, and what should I expect?
A: Yes, a mandatory pre-test genetic counselling session is required to draw a comprehensive pedigree chart of affected family members, ensuring you fully understand the clinical implications, inheritance pattern, and potential psychosocial impact of receiving genetic test results before proceeding. During this session, a certified genetic counsellor will review your family history across at least three generations, explain the X-linked recessive inheritance pattern of FTSJ1-related intellectual disability, discuss the possibility of incidental findings, and address any concerns about data privacy under UAE PDPL regulations. Post-test counselling is also included to help you interpret results and plan appropriate medical follow-up.
الجواب: نعم، جلسة الاستشارة الوراثية قبل الفحص إلزامية لرسم مخطط نسب شامل لأفراد العائلة المصابين، مما يضمن فهمك الكامل للآثار السريرية ونمط الوراثة والتأثير النفسي والاجتماعي المحتمل لنتائج الفحص الجيني قبل المتابعة.
Clinical Specialists Involved in Care Pathway
Neurologist
Primary specialist for clinical evaluation, neurological examination, and management of neurodevelopmental disorders. Oversees the diagnostic workup and coordinates multidisciplinary care for patients with intellectual disability.
Medical Geneticist / PhD Researcher
Interprets complex NGS data, classifies genetic variants per ACMG 2026 standards, and provides expert consultation on genotype-phenotype correlations for accurate molecular diagnosis.
Genetic Counsellor
Conducts mandatory pre-test pedigree analysis, facilitates informed consent, and provides post- counselling to help families understand inheritance patterns and reproductive options.
UAE Regulatory Compliance & Accreditation
This medical service operates in full compliance with Federal Decree-Law No. 41 of 2024 (Art. 87) governing genetic testing and healthcare data, the UAE PDPL (Personal Data Protection Law) for genetic data privacy, and CDS Law 2026 provisions for minors. Facility License: 9834453. Accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All genetic testing is performed in DHA-licensed laboratories following 2026 DHA clinical guidelines. Direct Billing Verification & Support: WhatsApp +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians